Michael F. Mahoney, Chairman, President & CEO at BOSTON SCIENTIFIC CORP (BSX), sold 325,556 shares at $84.74 ($27.6M) on 2024-11-05, disclosed to the SEC on 2024-11-07.
Scheduled sale ($27.6M) by Chairman, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.74 | 160,182 | $13.6M | 49.2% |
| 2 | $84.74 | 160,182 | $13.6M | 49.2% |
| 3 | $85.17 | 2,596 | $221K | 0.8% |
| 4 | $85.17 | 2,596 | $221K | 0.8% |
| Total | $84.75 avg | 325,556 | $27.6M | 100% |
| Filing → |
| BSX | SELL | 2025-05-05 | $33.7M | — | Filing → |
| BSX | SELL | 2025-04-02 | $32.9M | — | Filing → |
| CVS | BUY | 2025-02-19 | $2.0M | — | Filing → |